Concepedia
Statistics
Publications
9
Citations
2.2K
H-Index
Active since
1994
Affiliations
Exelixis (United States)(Current)
Stanford University
Fawn Qian is an author at Exelixis (United States) specializing in oncology, medicine, and pharmacology.
Publications per year
1994–2015
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
F. Michael Yakes, Jason Chen, Jenny Tan et al. · Molecular Cancer Therapeutics · 2011 · 1.3K citations · Full text
Medicine, Oncology, Pharmacology +17
Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
Fawn Qian, Stefan Engst, Peiwen Yu et al. · Cancer Research · 2009 · 338 citations
Expression of the integrin $alpha;4$beta;1 on melanoma cells can inhibit the invasive stage of metastasis formation
Fawn Qian · Cell · 1994 · 218 citations
Medicine, Cell Biology, Oncology +15
L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis
Fawn Qian, Douglas Hanahan, Irving L. Weissman · Proceedings of the National Academy of Sciences · 2001 · 85 citations · Full text
Medicine, Cancer Biology, Oncology +17
Characterization of the Activity of the PI3K/mTOR Inhibitor XL765 (SAR245409) in Tumor Models with Diverse Genetic Alterations Affecting the PI3K Pathway
Peiwen Yu, Alexander Laird, Xiangnan Du et al. · Molecular Cancer Therapeutics · 2014 · 78 citations
1–5 of 9